Combined inhibition of β-catenin and Bcr–Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo

Tyrosine kinase inhibitor (TKI) resistance and progression to blast crisis (BC), both related to persistent β-catenin activation, remain formidable challenges for chronic myeloid leukemia (CML). We observed overexpression of β-catenin in BC-CML stem/progenitor cells, particularly in granulocyte–macr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, H, Mak, P Y, Mu, H, Mak, D H, Zeng, Z, Cortes, J, Liu, Q, Andreeff, M, Carter, B Z
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628102/
https://www.ncbi.nlm.nih.gov/pubmed/28321124
http://dx.doi.org/10.1038/leu.2017.87

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628102/
https://www.ncbi.nlm.nih.gov/pubmed/28321124
http://dx.doi.org/10.1038/leu.2017.87

Ejemplares similares